Shockwave Medical, Inc. Common Stock
SWAV
SWAV was delisted on the 30th of May, 2024.
410 hedge funds and large institutions have $9.23B invested in Shockwave Medical, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 103 funds opening new positions, 129 increasing their positions, 135 reducing their positions, and 27 closing their positions.
281% more first-time investments, than exits
New positions opened: 103 | Existing positions closed: 27
83% more call options, than puts
Call options by funds: $167M | Put options by funds: $91.1M
39% more capital invested
Capital invested by funds: $6.63B → $9.23B (+$2.6B)
22% more funds holding
Funds holding: 336 → 410 (+74)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
4% less repeat investments, than reductions
Existing positions increased: 129 | Existing positions reduced: 135
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$71.1M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$49.4M |
| 3 |
Goldman Sachs
New York
|
+$47.8M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$43.1M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$39.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$361M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$57.5M |
| 3 |
JP Morgan Chase
New York
|
-$49.4M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$45.6M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$42.8M |
SWAV Hedge Fund Activity: Q3 2022 in Review
410 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Shockwave Medical, Inc. Common Stock (SWAV) for Q3 2022, worth a combined $9.23B — up 39% from $6.63B a quarter earlier.
Buyers outnumbered sellers: 103 funds opened new SWAV positions and 27 closed out — a net gain of 76 holders — while 129 added to existing stakes and 135 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $71.1M. The largest seller was T. Rowe Price Associates, cutting an estimated $361M.
- 410 institutional investors held Shockwave Medical, Inc. Common Stock (SWAV) as of Q3 2022, up from 336 in Q2 2022.
- Funds reported $9.23B of Shockwave Medical, Inc. Common Stock stock for Q3 2022, up 39% quarter-over-quarter.
- 103 funds opened new Shockwave Medical, Inc. Common Stock positions in Q3 2022 and 27 closed out, a net change of +76 holders.
- The largest Shockwave Medical, Inc. Common Stock buyer in Q3 2022 was Renaissance Technologies, an estimated $71.1M added.
- The largest Shockwave Medical, Inc. Common Stock seller in Q3 2022 was T. Rowe Price Associates, an estimated $361M sold.
Based on aggregated 13F filings for Q3 2022.